Kuraray to Buy Calgon Carbon for $1.1 Billion

(c) Calgon Carbon
(c) Calgon Carbon

Japanese chemicals, resins and fibers group Kuraray has reached agreement to buy US activated carbon company Calgon Carbon for $1.1 billion.

Under terms of the deal, Kuraray will pay Calgon’s shareholders $21.50 per share in cash, which represents a premium of more than 60% to the Pittsburgh group’s stock price of $13.20 the day before the merger was announced on Sept. 21.  Both companies’ boards of directors have unanimously approved the acquisition.

The transaction is expected to close at the end of December, after which Calgon will operate as a wholly owned subsidiary and serve as the headquarters of a global business providing filtration media, services and equipment to water-treatment customers.

Calgon employs around 1,400 people and operates 20 facilities in Europe, USA and Asia. It posted a net income last year of $13.8 million on sales of $514.2 million.

Randy Dearth, Calgon’s CEO, said the merger will make his company part of a much larger, stronger global company with the resources to support its businesses well into the future.

Calgon paid $153 million for Arkema’s activated carbon business last year, adding wood-based activated carbon to its leading coal-based portfolio and boosting its platform to invest in the emerging markets of Asia and South America.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.